Clinical Trial Update: Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing single-dose methotrexate and methotrexate plus actinomycin-D in low-risk gestational trophoblastic neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Disease
• Gestational Trophoblastic Neoplasia
• Gestational Trophoblastic Neoplasms
• Gestational Trophoblastic Tumor

Drugs mentioned

• Actinomycin D (dactinomycin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Ding Ma | Conditions: Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia | Phase 3 | Status: UNKNOWN